(+)-alpha-tocopherol multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR mRNA], alpha-Tocopherol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR protein] CTD PMID:10428045 (-)-demecolcine decreases expression ISO RGD:69120 6480464 Demecolcine results in decreased expression of PAWR mRNA CTD PMID:23649840 (S)-colchicine increases expression EXP 6480464 Colchicine results in increased expression of PAWR protein CTD PMID:12941380 (S)-colchicine multiple interactions EXP 6480464 alvocidib inhibits the reaction [Colchicine results in increased expression of PAWR protein] CTD PMID:12941380 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PAWR protein CTD PMID:15964511 17beta-estradiol multiple interactions EXP 6480464 Estradiol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR mRNA], Estradiol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR protein] CTD PMID:10428045 17beta-estradiol increases expression ISO RGD:69120 6480464 Estradiol results in increased expression of PAWR mRNA, Estradiol results in increased expression of PAWR protein CTD PMID:20106945 , PMID:20945400 17beta-estradiol multiple interactions ISO RGD:69120 6480464 EGF protein inhibits the reaction [Estradiol results in decreased expression of PAWR mRNA] CTD PMID:24758408 17beta-estradiol decreases expression ISO RGD:69120 6480464 Estradiol results in decreased expression of PAWR mRNA CTD PMID:24758408 1H-pyrazole increases expression ISO RGD:737403 6480464 pyrazole results in increased expression of PAWR mRNA CTD PMID:17945193 2-butoxyethanol increases expression ISO RGD:737403 6480464 n-butoxyethanol results in increased expression of PAWR mRNA CTD PMID:19812364 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of PAWR mRNA CTD PMID:19162173 4-hydroxyphenyl retinamide increases expression ISO RGD:737403 6480464 Fenretinide results in increased expression of PAWR mRNA CTD PMID:28973697 4-phenylbutyric acid decreases expression ISO RGD:69120 6480464 4-phenylbutyric acid results in decreased expression of PAWR mRNA CTD PMID:14583596 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions EXP 6480464 Uric Acid inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR mRNA], Uric Acid inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR protein] CTD PMID:10428045 aflatoxin B1 increases expression ISO RGD:69120 6480464 Aflatoxin B1 results in increased expression of PAWR mRNA CTD PMID:27153756 aflatoxin B2 increases methylation ISO RGD:69120 6480464 aflatoxin B2 results in increased methylation of PAWR intron CTD PMID:30157460 all-trans-retinoic acid affects localization ISO RGD:69120 6480464 Tretinoin affects the localization of PAWR protein CTD PMID:12644474 alvocidib multiple interactions EXP 6480464 alvocidib inhibits the reaction [Colchicine results in increased expression of PAWR protein] CTD PMID:12941380 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PAWR mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:69120 6480464 Antirheumatic Agents results in increased expression of PAWR mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:737403 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of PAWR mRNA CTD PMID:23650126 arsenous acid increases expression ISO RGD:69120 6480464 Arsenic Trioxide results in increased expression of PAWR mRNA, Arsenic Trioxide results in increased expression of PAWR protein CTD PMID:16966277 beauvericin decreases expression ISO RGD:69120 6480464 beauvericin results in decreased expression of PAWR mRNA CTD PMID:29203277 benzo[a]pyrene decreases expression ISO RGD:737403 6480464 Benzo(a)pyrene results in decreased expression of PAWR mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:69120 6480464 Benzo(a)pyrene affects the methylation of PAWR intron CTD PMID:30157460 benzo[a]pyrene increases expression ISO RGD:737403 6480464 Benzo(a)pyrene results in increased expression of PAWR mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:69120 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PAWR mRNA CTD PMID:25181051 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PAWR gene CTD PMID:28505145 bortezomib multiple interactions ISO RGD:69120 6480464 [BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased expression of PAWR mRNA CTD PMID:25522274 carbon nanotube increases expression ISO RGD:737403 6480464 Nanotubes, Carbon analog results in increased expression of PAWR mRNA CTD PMID:25554681 carboplatin decreases expression EXP 6480464 Carboplatin results in decreased expression of PAWR mRNA CTD PMID:18172885 choline multiple interactions ISO RGD:737403 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PAWR gene CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of PAWR mRNA CTD PMID:18172885 cisplatin decreases expression ISO RGD:69120 6480464 Cisplatin results in decreased expression of PAWR mRNA CTD PMID:27392435 cisplatin decreases response to substance ISO RGD:69120 6480464 PAWR mutant form results in decreased susceptibility to Cisplatin CTD PMID:24144893 cisplatin multiple interactions ISO RGD:69120 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PAWR mutant form results in decreased susceptibility to Cisplatin] more ... CTD PMID:20705681 more ... cladribine multiple interactions ISO RGD:69120 6480464 Cladribine promotes the reaction [Bendamustine Hydrochloride results in decreased expression of PAWR protein] CTD PMID:12948851 clofibrate increases expression ISO RGD:737403 6480464 Clofibrate results in increased expression of PAWR mRNA CTD PMID:17585979 cobalt dichloride increases expression ISO RGD:69120 6480464 cobaltous chloride results in increased expression of PAWR mRNA CTD PMID:19376846 copper(II) sulfate increases expression ISO RGD:69120 6480464 Copper Sulfate results in increased expression of PAWR mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:69120 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAWR mRNA CTD PMID:19167446 coumestrol decreases expression ISO RGD:69120 6480464 Coumestrol results in decreased expression of PAWR mRNA CTD PMID:19167446 cyclosporin A increases expression ISO RGD:69120 6480464 Cyclosporine results in increased expression of PAWR mRNA CTD PMID:20106945 , PMID:25562108 dextran sulfate decreases expression ISO RGD:737403 6480464 Dextran Sulfate results in decreased expression of PAWR protein CTD PMID:32272095 dextran sulfate multiple interactions ISO RGD:737403 6480464 Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of PAWR protein] CTD PMID:32272095 diarsenic trioxide increases expression ISO RGD:69120 6480464 Arsenic Trioxide results in increased expression of PAWR mRNA, Arsenic Trioxide results in increased expression of PAWR protein CTD PMID:16966277 dibutyl phthalate increases expression ISO RGD:737403 6480464 Dibutyl Phthalate results in increased expression of PAWR mRNA CTD PMID:17361019 , PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of PAWR mRNA CTD PMID:21266533 , PMID:21745491 dichloroacetic acid increases expression ISO RGD:737403 6480464 Dichloroacetic Acid results in increased expression of PAWR mRNA CTD PMID:28962523 dioxygen multiple interactions ISO RGD:737403 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PAWR mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:69120 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PAWR mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:69120 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAWR mRNA CTD PMID:19167446 fluoranthene multiple interactions ISO RGD:737403 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of PAWR mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:737403 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PAWR gene CTD PMID:20938992 folic acid decreases expression ISO RGD:737403 6480464 Folic Acid results in decreased expression of PAWR mRNA CTD PMID:25629700 furan decreases methylation EXP 6480464 furan results in decreased methylation of PAWR gene CTD PMID:27387713 hydrogen peroxide affects expression ISO RGD:69120 6480464 Hydrogen Peroxide affects the expression of PAWR mRNA CTD PMID:23410634 irinotecan decreases expression ISO RGD:69120 6480464 Irinotecan results in decreased expression of PAWR mRNA CTD PMID:20185912 isotretinoin decreases expression ISO RGD:69120 6480464 Isotretinoin results in decreased expression of PAWR mRNA CTD PMID:20436886 L-methionine multiple interactions ISO RGD:737403 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PAWR gene CTD PMID:20938992 leflunomide increases expression ISO RGD:69120 6480464 leflunomide results in increased expression of PAWR mRNA CTD PMID:28988120 LY294002 multiple interactions ISO RGD:69120 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PAWR mutant form results in decreased susceptibility to Cisplatin] CTD PMID:24144893 melatonin decreases expression EXP 6480464 Melatonin results in decreased expression of PAWR protein CTD PMID:15964511 menadione affects expression ISO RGD:69120 6480464 Vitamin K 3 affects the expression of PAWR mRNA CTD PMID:23410634 mercury dibromide increases expression ISO RGD:69120 6480464 mercuric bromide results in increased expression of PAWR mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:69120 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAWR mRNA CTD PMID:27188386 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of PAWR mRNA CTD PMID:19564919 methylmercury chloride increases expression ISO RGD:69120 6480464 methylmercuric chloride results in increased expression of PAWR mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:69120 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAWR mRNA CTD PMID:27188386 miglustat multiple interactions ISO RGD:737403 6480464 miglustat inhibits the reaction [[ST8SIA1 protein affects the abundance of Gangliosides] which results in decreased expression of PAWR protein] CTD PMID:11574545 N-nitrosodiethylamine increases expression ISO RGD:737403 6480464 Diethylnitrosamine results in increased expression of PAWR mRNA CTD PMID:24535843 nimesulide increases expression ISO RGD:69120 6480464 nimesulide results in increased expression of PAWR mRNA CTD PMID:10833474 NS-398 increases expression ISO RGD:69120 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of PAWR mRNA CTD PMID:10833474 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PAWR mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of PAWR mRNA CTD PMID:25729387 p-menthan-3-ol increases expression ISO RGD:69120 6480464 Menthol results in increased expression of PAWR mRNA CTD PMID:26760959 paclitaxel multiple interactions ISO RGD:69120 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of PAWR mRNA CTD PMID:20705681 paracetamol affects expression ISO RGD:737403 6480464 Acetaminophen affects the expression of PAWR mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:69120 6480464 Acetaminophen results in decreased expression of PAWR mRNA CTD PMID:27761495 perfluorooctanoic acid increases expression ISO RGD:69120 6480464 perfluorooctanoic acid results in increased expression of PAWR protein CTD PMID:26879310 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of PAWR mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:69120 6480464 Phenobarbital affects the expression of PAWR mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:69120 6480464 Phenylmercuric Acetate results in increased expression of PAWR mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:69120 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAWR mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:737403 6480464 pirinixic acid results in increased expression of PAWR mRNA CTD PMID:18301758 potassium chromate decreases expression ISO RGD:69120 6480464 potassium chromate(VI) results in decreased expression of PAWR mRNA CTD PMID:22714537 propiconazole increases expression ISO RGD:737403 6480464 propiconazole results in increased expression of PAWR mRNA CTD PMID:21278054 raloxifene increases expression ISO RGD:69120 6480464 Raloxifene Hydrochloride results in increased expression of PAWR mRNA, Raloxifene Hydrochloride results in increased expression of PAWR protein CTD PMID:20945400 SB 431542 multiple interactions ISO RGD:69120 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SC-58125 increases expression ISO RGD:69120 6480464 1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole results in increased expression of PAWR mRNA CTD PMID:10833474 silver atom increases expression ISO RGD:69120 6480464 Silver results in increased expression of PAWR mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:69120 6480464 Silver results in increased expression of PAWR mRNA CTD PMID:26014281 sodium arsenite increases expression ISO RGD:69120 6480464 sodium arsenite results in increased expression of PAWR mRNA, sodium arsenite results in increased expression of PAWR protein CTD PMID:16966277 Soman increases expression EXP 6480464 Soman results in increased expression of PAWR mRNA CTD PMID:19281266 sulindac sulfide increases expression ISO RGD:69120 6480464 sulindac sulfide results in increased expression of PAWR mRNA CTD PMID:10833474 sunitinib increases expression ISO RGD:69120 6480464 Sunitinib results in increased expression of PAWR mRNA CTD PMID:31533062 tert-butyl hydroperoxide affects expression ISO RGD:69120 6480464 tert-Butylhydroperoxide affects the expression of PAWR mRNA CTD PMID:23410634 testosterone increases response to substance ISO RGD:737403 6480464 PAWR gene mutant form results in increased susceptibility to Testosterone CTD PMID:15877079 tetrachloromethane increases expression ISO RGD:737403 6480464 Carbon Tetrachloride results in increased expression of PAWR mRNA CTD PMID:31919559 tetrahydropalmatine decreases expression ISO RGD:69120 6480464 tetrahydropalmatine results in decreased expression of PAWR protein CTD PMID:20109541 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PAWR mRNA CTD PMID:23411599 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PAWR mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of PAWR mRNA CTD PMID:25729387 triadimefon decreases expression ISO RGD:69120 6480464 triadimefon results in decreased expression of PAWR mRNA CTD PMID:26705709 trichloroethene increases expression ISO RGD:737403 6480464 Trichloroethylene results in increased expression of PAWR mRNA CTD PMID:25549359 trichostatin A increases expression ISO RGD:69120 6480464 trichostatin A results in increased expression of PAWR mRNA CTD PMID:24935251 valproic acid increases methylation ISO RGD:69120 6480464 Valproic Acid results in increased methylation of PAWR gene CTD PMID:29154799 valproic acid increases expression ISO RGD:69120 6480464 Valproic Acid results in increased expression of PAWR mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:69120 6480464 Valproic Acid affects the expression of PAWR mRNA CTD PMID:25979313 vitamin E multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR mRNA], alpha-Tocopherol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR protein] CTD PMID:10428045 vitamin E decreases expression ISO RGD:69120 6480464 Vitamin E results in decreased expression of PAWR mRNA CTD PMID:19244175
Biological Process actin filament bundle assembly IDA 8554822 PMID:16229834 UniProt activation of cysteine-type endopeptidase activity IMP 9835366 RGD apoptotic process IDA 8554822 PMID:16229834 UniProt apoptotic process IEP 9835345 RGD apoptotic signaling pathway ISO RGD:737403 1624291 MGI:MGI:1197015 more ... RGD MGI:MGI:3687891 , PMID:12917339 apoptotic signaling pathway IEA UniProtKB:Q925B0 , ensembl:ENSMUSP000000929511600115 GO_REF:0000107 Ensembl GO_REF:0000107 calcium ion import across plasma membrane IDA 9835370 RGD cellular response to estradiol stimulus IEP 9835341 RGD cellular response to follicle-stimulating hormone stimulus IEP 9835345 RGD cellular response to interleukin-1 IEP 9835367 RGD cellular response to vitamin E IEP 9835341 RGD detection of mechanical stimulus involved in sensory perception of pain IDA 9835398 RGD detection of temperature stimulus involved in sensory perception of pain IDA 9835416 RGD interleukin-2 production ISO RGD:737403 1624291 MGI:MGI:2678021 (MGI:MGI:2675524 , PMID:12970181) RGD MGI:MGI:2675524 , PMID:12970181 negative regulation of B cell proliferation ISO RGD:737403 1624291 MGI:MGI:2678021 (MGI:MGI:2675524 , PMID:12970181) RGD MGI:MGI:2675524 , PMID:12970181 negative regulation of B cell proliferation IEA UniProtKB:Q925B0 , ensembl:ENSMUSP000000929511600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of calcium ion import IDA 9835416 RGD negative regulation of fibroblast proliferation ISO RGD:737403 1624291 (MGI:MGI:5648604, PMID:25472717) RGD MGI:MGI:5648604 , PMID:25472717 negative regulation of fibroblast proliferation IEA UniProtKB:Q925B0 , ensembl:ENSMUSP000000929511600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of gene expression ISO RGD:737403 1624291 (MGI:MGI:5648604, PMID:25472717) RGD MGI:MGI:5648604 , PMID:25472717 negative regulation of T cell proliferation ISO RGD:737403 1624291 MGI:MGI:2678021 (MGI:MGI:2675524 , PMID:12970181) RGD MGI:MGI:2675524 , PMID:12970181 negative regulation of T cell proliferation IEA UniProtKB:Q925B0 , ensembl:ENSMUSP000000929511600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of T cell receptor signaling pathway ISO RGD:737403 1624291 MGI:MGI:2678021 (MGI:MGI:2675524 , PMID:12970181) RGD MGI:MGI:2675524 , PMID:12970181 negative regulation of T cell receptor signaling pathway IEA UniProtKB:Q925B0 , ensembl:ENSMUSP000000929511600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of transcription by RNA polymerase II ISO RGD:737403 1624291 (MGI:MGI:5648604, PMID:25472717) RGD MGI:MGI:5648604 , PMID:25472717 negative regulation of transcription by RNA polymerase II IEA UniProtKB:Q925B0 , ensembl:ENSMUSP000000929511600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of action potential IDA 9835398 RGD positive regulation of amyloid precursor protein biosynthetic process ISO RGD:737403 1624291 (MGI:MGI:3028747, PMID:14627703) RGD MGI:MGI:3028747 , PMID:14627703 positive regulation of amyloid precursor protein biosynthetic process IEA UniProtKB:Q925B0 , ensembl:ENSMUSP000000929511600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of apoptotic process IMP 9835341 RGD positive regulation of apoptotic process IBA PANTHER:PTN001031308 , RGD:69065 13792537 PMID:21873635 GO_Central positive regulation of cellular senescence ISO RGD:737403 1624291 (MGI:MGI:5648604, PMID:25472717) RGD MGI:MGI:5648604 , PMID:25472717 positive regulation of cellular senescence IEA UniProtKB:Q925B0 , ensembl:ENSMUSP000000929511600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of gene expression ISO RGD:737403 1624291 (MGI:MGI:5648604, PMID:25472717) RGD MGI:MGI:5648604 , PMID:25472717 positive regulation of gene expression IEA UniProtKB:Q925B0 , ensembl:ENSMUSP000000929511600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of hindgut contraction IDA 9835340 RGD positive regulation of hydrogen peroxide-mediated programmed cell death ISO RGD:737403 1624291 (MGI:MGI:5648604, PMID:25472717) RGD MGI:MGI:5648604 , PMID:25472717 positive regulation of hydrogen peroxide-mediated programmed cell death IEA UniProtKB:Q925B0 , ensembl:ENSMUSP000000929511600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of leukocyte tethering or rolling IDA 9835372 RGD positive regulation of neuron apoptotic process IMP 9835381 RGD positive regulation of neuronal action potential IMP 9835339 RGD positive regulation of neutrophil extravasation IDA 9835372 RGD positive regulation of phosphoprotein phosphatase activity IMP 9835413 RGD positive regulation of relaxation of smooth muscle IDA 9835373 RGD response to estradiol IEP 9835363 RGD response to iron(II) ion IEP 9835366 RGD response to lipopolysaccharide IEP 9835397 RGD response to wounding IEP 1299297 RGD Cellular Component actin cytoskeleton ISO RGD:69120 1624291 RGD GO_REF:0000052 actin cytoskeleton IEA UniProtKB:Q96IZ0 , ensembl:ENSP000003280881600115 GO_REF:0000107 Ensembl GO_REF:0000107 actin filament colocalizes_with IDA 8554822 PMID:16229834 UniProt actin filament colocalizes_with IDA 9835355 RGD axon IDA 9835383 RGD cytoplasm ISO RGD:737403 1624291 (MGI:MGI:3028747, PMID:14627703) RGD MGI:MGI:3028747 , PMID:14627703 cytoplasm IBA MGI:MGI:2149961 more ... 13792537 PMID:21873635 GO_Central cytoplasm IEA UniProtKB:Q96IZ0 , ensembl:ENSP000003280881600115 GO_REF:0000107 Ensembl GO_REF:0000107 cytoplasm IEA UniProtKB:Q925B0 , ensembl:ENSMUSP000000929511600115 GO_REF:0000107 Ensembl GO_REF:0000107 cytoplasm IDA 9835360 RGD cytoplasm ISO RGD:69120 1624291 (PMID:14627703) RGD PMID:14627703 neuron projection IDA 9835366 RGD neuronal cell body IDA 9835366 RGD nuclear chromatin ISO RGD:737403 1624291 (MGI:MGI:5648604, PMID:25472717) RGD MGI:MGI:5648604 , PMID:25472717 nuclear chromatin IEA UniProtKB:Q925B0 , ensembl:ENSMUSP000000929511600115 GO_REF:0000107 Ensembl GO_REF:0000107 nucleus ISO RGD:69120 1624291 (PMID:14627703) RGD PMID:14627703 nucleus ISO RGD:737403 1624291 (MGI:MGI:3028747 more ... RGD MGI:MGI:3028747 more ... plasma membrane ISO RGD:69120 1624291 RGD GO_REF:0000052 plasma membrane IEA UniProtKB:Q96IZ0 , ensembl:ENSP000003280881600115 GO_REF:0000107 Ensembl GO_REF:0000107 Molecular Function actin binding IDA 8554822 PMID:16229834 UniProt enzyme binding ISO RGD:69120 1624291 (PMID:15671026) RGD PMID:15671026 enzyme binding IEA UniProtKB:Q96IZ0 , ensembl:ENSP000003280881600115 GO_REF:0000107 Ensembl GO_REF:0000107 leucine zipper domain binding ISO RGD:69120 1624291 UniProtKB:Q9NY61 (PMID:14627703) RGD PMID:14627703 leucine zipper domain binding IEA UniProtKB:Q96IZ0 , ensembl:ENSP000003280881600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein binding IPI RGD:621766 8554171 RGD protein binding ISO RGD:69120 1624291 UniProtKB:O88838 more ... RGD PMID:11755531 more ... protein binding IPI UniProtKB:P11021 8553900 PMID:19632185 IntAct protein binding IPI RGD:620013 9835413 RGD protein binding IPI UniProtKB:O88764 8554171 PMID:10602480 IntAct protein binding IPI UniProtKB:Q9JMG6 8554822 PMID:16229834 UniProt protein binding IPI RGD:733323 9835368 RGD protein binding ISO RGD:737403 1624291 PR:Q9JKX4 more ... RGD MGI:MGI:3028747 more ... protein kinase C binding IPI RGD:3399 9835345 RGD protein phosphatase 1 binding IPI RGD:3376 , RGD:620013 9835415 RGD
Gene-Chemical Interaction Annotations
